• 1
    Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. and Baxter, A. G., NKT cells: facts, functions and fallacies. Immunol. Today 2000. 21: 573583.
  • 2
    Porcelli, S., Yockey, C. E., Brenner, M. B. and Balk, S. P., Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD48 alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J. Exp. Med. 1993. 178: 116.
  • 3
    Dellabona, P., Padovan, E., Casorati, G., Brockhaus, M. and Lanzavecchia, A., An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD48 T cells. J. Exp. Med. 1994. 180: 11711176.
  • 4
    Exley, M., Garcia, J., Balk, S. P. and Porcelli, S., Requirements for CD1d recognition by human invariant Valpha24+ CD4CD8 T cells. J. Exp. Med. 1997. 186: 109120.
  • 5
    Porcelli, S. A. and Modlin, R. L., The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 1999. 17: 297329.
  • 6
    Kitamura, H., Iwakabe, K., Yahata, T., Nishimura, S., Ohta, A., Ohmi, Y., Sato, M., Takeda, K., Okumura, K., Van Kaer, L., Kawano, T., Taniguchi, M. and Nishimura, T., The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 1999. 189: 11211128.
  • 7
    Yang, O. O., Racke, F. K., Nguyen, P. T., Gausling, R., Severino, M. E., Horton, H. F., Byrne, M. C., Strominger, J. L. and Wilson, S. B., CD1d on myeloid dendritic cells stimulates cytokine secretion from and cytolytic activity of V alpha 24J alpha Q T cells: a feedback mechanism for immune regulation. J. Immunol. 2000. 165: 37563762.
  • 8
    Davodeau, F., Peyrat, M. A., Necker, A., Dominici, R., Blanchard, F., Leget, C., Gaschet, J., Costa, P., Jacques, Y., Godard, A., Vie, H., Poggi, A., Romagne, F. and Bonneville, M., Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains. J. Immunol. 1997. 158: 56035611.
  • 9
    Takahashi, T., Nieda, M., Koezuka, Y., Nicol, A., Porcelli, S. A., Ishikawa, Y., Tadokoro, K., Hirai, H. and Juji, T., Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 2000. 164: 44584464.
  • 10
    Lee, P. T., Benlagha, K., Teyton, L. and Bendelac, A., Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 2002. 195: 637641.
  • 11
    Sandberg, J. K., Fast, N. M., Palacios, E. H., Fennelly, G., Dobroszycki, J., Palumbo, P., Wiznia, A., Grant, R. M., Bhardwaj, N., Rosenberg, M. G. and Nixon, D. F., Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J. Virol. 2002. 76: 75287534.
  • 12
    Gumperz, J. E., Miyake, S., Yamamura, T. and Brenner, M. B., Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 2002. 195: 625636.
  • 13
    Nakagawa, R., Motoki, K., Ueno, H., Iijima, R., Nakamura, H., Kobayashi, E., Shimosaka, A. and Koezuka, Y., Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000. Cancer Res. 1998. 58: 12021207.
  • 14
    Smyth, M. J., Thia, K. Y., Street, S. E., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y. and Godfrey, D. I., Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 2000. 191: 661668.
  • 15
    Carnaud, C., Lee, D., Donnars, O., Park, S. H., Beavis, A., Koezuka, Y. and Bendelac, A., Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 1999. 163: 46474650.
  • 16
    Ishihara, S., Nieda, M., Kitayama, J., Osada, T., Yabe, T., Kikuchi, A., Koezuka, Y., Porcelli, S. A., Tadokoro, K., Nagawa, H. and Juji, T., Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patientsby activating CD3CD56+ NK cells in vitro. J. Immunol. 2000. 165: 16591664.
  • 17
    Sumida, T., Sakamoto, A., Murata, H., Makino, Y., Takahashi,H., Yoshida, S., Nishioka, K., Iwamoto, I. and Taniguchi, M., Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J. Exp. Med. 1995. 182: 11631168.
  • 18
    Illes, Z., Kondo, T., Newcombe, J., Oka, N., Tabira, T. and Yamamura, T., Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 2000. 164: 43754381.
  • 19
    Oishi, Y., Sumida, T., Sakamoto, A., Kita, Y., Kurasawa, K., Nawata, Y., Takabayashi, K., Takahashi, H., Yoshida, S., Taniguchi, M., Saito, Y. and Iwamoto, I., Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor Tcells in correlation with disease activity in patients with systemic lupus erythematosus. J. Rheumatol. 2001. 28: 275283.
  • 20
    Yanagihara, Y., Shiozawa, K., Takai, M., Kyogoku, M. and Shiozawa, S., Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA). Clin. Exp. Immunol. 1999. 118: 131136.
  • 21
    Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S., Schatz, D. A., Atkinson, M. A., Balk, S. P., Strominger, J. L. and Hafler, D. A., Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998. 391: 177181.
  • 22
    Lee, P. T., Putnam, A., Benlagha, K., Teyton, L., Gottlieb, P. A. and Bendelac, A., Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 2002. 110:793800.
  • 23
    van der Vliet, H. J., von Blomberg, B. M., Hazenberg, M. D., Nishi, N., Otto, S. A., van Benthem, B. H., Prins, M., Claessen, F. A., van den Eertwegh, A. J., Giaccone, G., Miedema, F., Scheper, R. J. and Pinedo, H. M., Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J. Immunol. 2002. 168: 14901495.
  • 24
    Motsinger, A., Haas, D. W., Stanic, A. K., Van Kaer, L., Joyce, S. and Unutmaz, D., CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J. Exp. Med. 2002. 195: 869879.
  • 25
    Hobbs, J. A., Cho, S., Roberts, T. J., Sriram, V., Zhang, J., Xu, M. and Brutkiewicz, R. R., Selective loss of natural killer t cells by apoptosis following infection with lymphocytic choriomeningitis virus. J. Virol. 2001. 75: 1074610754.
  • 26
    Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708712.
  • 27
    Sallusto, F., Mackay, C. R. and Lanzavecchia, A., The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 2000. 18: 593620.
  • 28
    Whitacre, C. C., Reingold, S. C. and O'Looney, P. A., A gender gap in autoimmunity. Science 1999. 283: 12771278.
  • 29
    Takahashi, T., Chiba, S., Nieda, M., Azuma, T., Ishihara, S., Shibata, Y., Juji, T. and Hirai, H., Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 2002. 168: 31403144.
  • 30
    van Der Vliet, H. J., Nishi, N., de Gruijl, T. D., von Blomberg, B. M., van den Eertwegh, A. J., Pinedo, H. M., Giaccone, G. and Scheper, R. J., Human natural killer T cells acquire a memory-activated phenotype before birth. Blood 2000. 95: 24402442.
  • 31
    Amadori, A., Zamarchi, R., De Silvestro, G., Forza, G., Cavatton, G., Danieli, G. A., Clementi, M. and Chieco-Bianchi, L., Genetic control of the CD4/CD8T cell ratio in humans. Nat. Med. 1995. 1: 12791283.
  • 32
    Hammond, K. J., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I. and Baxter, A. G., alpha/beta-T cell receptor (TCR)+CD4CD8 (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 1998. 187: 10471056.
  • 33
    Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T., Haba, T., Scherer, D. C., Wei, J., Kronenberg, M., Koezuka, Y. and Van Kaer, L., The natural killer T cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 10521056.
  • 34
    Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J. F. and Monteiro, R. C., Overexpression of natural killer T cells protects Valpha14-Jalpha281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 1998. 188: 18311839.
  • 35
    Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M., Koezuka, Y., Delovitch, T. L., Gombert, J. M., Leite-De-Moraes, M., Gouarin, C., Zhu, R., Hameg, A., Nakayama, T., Taniguchi, M., Lepault, F., Lehuen, A., Bach, J. F. and Herbelin, A., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001. 7: 10571062.
  • 36
    Diwan, V. K. and Thorson, A., Sex, gender, and tuberculosis. Lancet 1999. 353: 10001001.
  • 37
    Moody, D. B., Besra, G. S., Wilson, I. A. and Porcelli, S. A., The molecular basis of CD1-mediated presentation of lipid antigens. Immunol. Rev. 1999. 172: 285296.
  • 38
    Nieuwenhuis, E. E., Matsumoto, T., Exley, M., Schleipman, R. A., Glickman, J., Bailey, D. T., Corazza, N., Colgan, S. P., Onderdonk, A. B. and Blumberg, R. S., CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 2002. 8: 588593.
  • 39
    Emoto, M., Emoto, Y., Buchwalow, I. B. and Kaufmann, S. H., Induction of IFN-γ-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette Guerin. Eur. J. Immunol. 1999. 29: 650659.
  • 40
    Gilmore, W., Weiner, L. P. and Correale, J., Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 1997. 158: 446451.
  • 41
    Dardenne, M., de Moraes, M., Kelly, P. A. and Gagnerault, M. C., Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry. Endocrinology 1994. 134: 21082114.
  • 42
    Kooijman, R., Willems, M., De Haas, C. J., Rijkers, G. T., Schuurmans, A. L., Van Buul-Offers, S. C., Heijnen, C. J. and Zegers, B. J., Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 1992. 131: 22442250.
  • 43
    Sandberg, J. K., Fast, N. M. and Nixon, D. F., Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8(+) T lymphocytes. J. Immunol. 2001. 167: 181187.